Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2003
05/22/2003WO2003042366A2 A novel saitohin gene and uses of same
05/22/2003WO2003042364A2 Identifying and controlling the growth of estrogen-responsive cells
05/22/2003WO2003042363A2 Eit-6, a polypeptide encoded by an estrogen regulated gene
05/22/2003WO2003042362A2 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
05/22/2003WO2003042359A2 Histamine receptor h3 polynucleotides
05/22/2003WO2003042358A2 Methods of using 48149, a human aminopeptidase family member
05/22/2003WO2003042357A2 Enzymes
05/22/2003WO2003042245A2 Growth hormone variations in humans and their uses
05/22/2003WO2003042240A2 Polypeptides of pseudomonas aeruginosa
05/22/2003WO2003042233A2 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry
05/22/2003WO2003042226A2 Single nucleotide polymorphisms in gh-1
05/22/2003WO2003041862A1 Device and method for preparing particles for analysis
05/22/2003WO2003041859A1 Method for reducing ligand leakage from affinity chromatography matrices
05/22/2003WO2003041830A2 Macroporous gel, its preparation and its use
05/22/2003WO2003041737A1 Treatment of inflammatory conditions
05/22/2003WO2003041733A1 Prion-detection business methods
05/22/2003WO2003041730A1 Ditacin agonists and antagonists for use in the treatment of metabolic disorders
05/22/2003WO2003041729A1 Ptp1b inhibitors and ligands
05/22/2003WO2003041654A2 Anti-estrogen and immune modulator combinations for treating breast cancer
05/22/2003WO2003041635A2 Methods and compositions for therapeutic treatment of cathepsin k complex-mediated disorders
05/22/2003WO2003041565A2 Method for diagnosis of helicobacter pylori infection
05/22/2003WO2003041562A2 Molecular cancer diagnosis using tumor gene expression signature
05/22/2003WO2003041560A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/22/2003WO2003041483A2 Method to study and mechanisms of biofilm-related antibiotic resistance
05/22/2003WO2003041481A2 Novel optical method for diagnosis and staging of premalignant and malignant human colonic tissues
05/22/2003WO2003027317A3 Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances
05/22/2003WO2003027255A3 Anti-fusion assay
05/22/2003WO2003027247A3 Modulation of stem cells using zinc finger proteins
05/22/2003WO2003023396A3 Soil profile force measurement using an instrumented tine
05/22/2003WO2003020883A3 Nuclear bodies
05/22/2003WO2003020763A3 Soluble t cell receptor
05/22/2003WO2003018066A3 A murine genomic polynucleotide sequence encoding a g-protein coupled receptor and methods of use therefor
05/22/2003WO2003016464A3 Cancer specific oligosaccharide sequences and use thereof
05/22/2003WO2003015627A3 In-situ adapter for an analyte testing device
05/22/2003WO2003012089A3 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
05/22/2003WO2003010292A3 Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors
05/22/2003WO2003006951A3 System and method of determining proteomic differences
05/22/2003WO2003004995A3 High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation
05/22/2003WO2003004993A3 Satterned composite membrane and stenciling method for the manufacture thereof
05/22/2003WO2003003904A3 Coactivators in the diagnosis and treatment of breast cancer
05/22/2003WO2003003007A3 Methods and compositions useful for the prediction of blood-brain barrier permeation
05/22/2003WO2003001207A3 Method and device for measuring changes in microviscosity serving as an immune test
05/22/2003WO2002102987A3 Methods and compositions based on protein interactions with mastermind
05/22/2003WO2002102836A3 Moraxella (branhamella) catarrhalis antigens
05/22/2003WO2002101011A3 Reagents and methods for detection and characterization of protein-protein interactions
05/22/2003WO2002100353A3 Cd10-activated prodrug compounds
05/22/2003WO2002100333A3 Inhibitors of reggamma
05/22/2003WO2002099436A3 Characterising polypeptides
05/22/2003WO2002098438A9 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use
05/22/2003WO2002094084A3 Bmpr1a involvement in juvenile polyposis
05/22/2003WO2002088740A3 Method
05/22/2003WO2002085298A3 Method for detecting breast cancer cells
05/22/2003WO2002084288A3 Individualization of therapy with antiarrhythmics
05/22/2003WO2002083839A3 P450 single nucleotide polymorphism biochip analysis
05/22/2003WO2002079436A3 Modulators of leukocyte activation, compositions and methods of use
05/22/2003WO2002078533A3 Integrated sample testing meter
05/22/2003WO2002077265A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding these human drug-metabolizing proteins, and uses thereof
05/22/2003WO2002074339B1 Deveice and method for the photodynamic diagnosis of tumor tissue
05/22/2003WO2002073212A3 Diagnostic screens for alzheimer's disease
05/22/2003WO2002068959A3 Detection of microorganisms in liquid hydrocarbon fuel
05/22/2003WO2002068685A3 Diagnostic test for the detection of chromosomal abnormalities in a fetus
05/22/2003WO2002068466A3 Hypoxia-regulated genes
05/22/2003WO2002066637A3 Method for collecting and using nuclear mrna
05/22/2003WO2002065132A3 Detectable compositions, methods of forming the same and detection techniques
05/22/2003WO2002064830A3 Method for detecting dna polymerisation
05/22/2003WO2002059369A3 Compositions and methods for the treatment of diseases related to faulty cholesterol regulation
05/22/2003WO2002055199A3 Method and apparatus for delivery of submicroliter volumes onto a substrate
05/22/2003WO2002054067A3 Detection of analytes
05/22/2003WO2002054062A3 Reference standards and processes for determining the purity or stability of amlodipine maleate
05/22/2003WO2002053740A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/22/2003WO2002051430A3 Methods of modulating toll-related receptor (trr) signaling
05/22/2003WO2002050283A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/22/2003WO2002046768A3 Proteins, genes and their use for diagnosis and treatment of chronic asthma
05/22/2003WO2002046754A3 Functional proteomics using double phage display screening
05/22/2003WO2002044722A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
05/22/2003WO2002044427A9 Cell based triple readout assay systems for identifying compounds that effect transcription
05/22/2003WO2002040998A3 Kit and method for determining multiple analytes
05/22/2003WO2002029050A3 Regulation of human secretin receptor-like gpcr
05/22/2003WO2002026780A3 Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
05/22/2003WO2002024146A3 Methods of decreasing or preventing pain using spicamycin derivatives
05/22/2003WO2002023202A3 Method to identify antibody targets based on mass spectrometry (maldi-tof)
05/22/2003WO2002022807A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof
05/22/2003WO2002018624A3 Assay method for evaluating cell responses to infection
05/22/2003WO2002017969A3 Reagents and methods for the diagnosis of cmv dissemination
05/22/2003WO2002008466A9 A systematic approach to mechanism-of-response analyses
05/22/2003WO2001079539A9 Method for using transfectable constructions from luciferase and from the promotor of the human period 1 gene for identifying novel active substances that influence the day/night rhythm and sleep
05/22/2003WO2001074298A3 Methods and compositions for regulating memory consolidation
05/22/2003WO2001068708A9 Human and humanized fap-alpha-specific antibodies
05/22/2003US20030097671 Inhibition of betaarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
05/22/2003US20030097667 For therapy of Alzheimers disease, diagnosis
05/22/2003US20030097227 Method of non-linear analysis of biological sequence data
05/22/2003US20030097223 Primer design system
05/22/2003US20030097220 System and methods for optimized drug delivery and progression of diseased and normal cells
05/22/2003US20030096987 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same
05/22/2003US20030096986 Methods and computer software products for selecting nucleic acid probes
05/22/2003US20030096982 Nucleotide sequences coding polypeptide for use in the treatment of immunological, reproductive and liver disorders
05/22/2003US20030096969 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/22/2003US20030096955 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096954 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and nervous system disorders
05/22/2003US20030096953 Protein mixture for use in the detection of microbiocides
1 ... 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 ... 3937